Published on: 23 April 2021 CHMP recommends EU approval of Roche’s ENSPRYNG (satralizumab) for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD) more
Published on: 23 April 2021 Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy more
